Biocept, Inc.
BIOC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$32,087 | -$2,824 | -$17,807 | -$25,138 |
| Dep. & Amort. | $1,655 | $2,637 | $1,001 | $773 |
| Deferred Tax | $0 | $0 | $0 | $14 |
| Stock-Based Comp. | $3,227 | $2,462 | $941 | $870 |
| Change in WC | $13,285 | $1,304 | -$6,268 | -$1,399 |
| Other Non-Cash | $631 | $111 | $2,345 | $1,831 |
| Operating Cash Flow | -$13,289 | $3,690 | -$19,787 | -$23,049 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$807 | -$1,572 | -$867 | -$735 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$807 | -$1,572 | -$867 | -$735 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $240 | $14,120 | $24,194 | $25,745 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,871 | $12,378 | $25,720 | $29,663 |
| Financing Cash Flow | -$1,871 | $12,378 | $25,720 | $29,663 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15,967 | $14,496 | $5,067 | $5,878 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,864 | $14,368 | $9,301 | $3,423 |
| End Cash | $12,897 | $28,864 | $14,368 | $9,301 |
| Free Cash Flow | -$14,096 | $2,118 | -$20,654 | -$23,785 |